These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23395155)

  • 1. Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease.
    Li H; Förstermann U
    Curr Opin Pharmacol; 2013 Apr; 13(2):161-7. PubMed ID: 23395155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological prevention of eNOS uncoupling.
    Li H; Forstermann U
    Curr Pharm Des; 2014; 20(22):3595-606. PubMed ID: 24180386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal.
    Förstermann U
    Biol Chem; 2006 Dec; 387(12):1521-33. PubMed ID: 17132097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling.
    Förstermann U; Li H
    Br J Pharmacol; 2011 Sep; 164(2):213-23. PubMed ID: 21198553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of atherosclerosis by interference with the vascular nitric oxide system.
    Li H; Förstermann U
    Curr Pharm Des; 2009; 15(27):3133-45. PubMed ID: 19754387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncoupling of endothelial nitric oxide synthase in cerebral vasculature of Tg2576 mice.
    Santhanam AV; d'Uscio LV; He T; Das P; Younkin SG; Katusic ZS
    J Neurochem; 2015 Sep; 134(6):1129-38. PubMed ID: 26111938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial nitric oxide synthase in vascular disease: from marvel to menace.
    Förstermann U; Münzel T
    Circulation; 2006 Apr; 113(13):1708-14. PubMed ID: 16585403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities.
    Kietadisorn R; Juni RP; Moens AL
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E481-95. PubMed ID: 22167522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress in vascular disease and its pharmacological prevention.
    Li H; Horke S; Förstermann U
    Trends Pharmacol Sci; 2013 Jun; 34(6):313-9. PubMed ID: 23608227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial Dysfunction Driven by Hypoxia-The Influence of Oxygen Deficiency on NO Bioavailability.
    Janaszak-Jasiecka A; Siekierzycka A; Płoska A; Dobrucki IT; Kalinowski L
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular Redox Signaling, Endothelial Nitric Oxide Synthase Uncoupling, and Endothelial Dysfunction in the Setting of Transportation Noise Exposure or Chronic Treatment with Organic Nitrates.
    Münzel T; Daiber A
    Antioxid Redox Signal; 2023 May; 38(13-15):1001-1021. PubMed ID: 36719770
    [No Abstract]   [Full Text] [Related]  

  • 12. Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets.
    Janaszak-Jasiecka A; Płoska A; Wierońska JM; Dobrucki LW; Kalinowski L
    Cell Mol Biol Lett; 2023 Mar; 28(1):21. PubMed ID: 36890458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease.
    Schmidt TS; Alp NJ
    Clin Sci (Lond); 2007 Jul; 113(2):47-63. PubMed ID: 17555404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease.
    Alp NJ; Channon KM
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):413-20. PubMed ID: 14656731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-glutathionylation reshapes our understanding of endothelial nitric oxide synthase uncoupling and nitric oxide/reactive oxygen species-mediated signaling.
    Zweier JL; Chen CA; Druhan LJ
    Antioxid Redox Signal; 2011 May; 14(10):1769-75. PubMed ID: 21261471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of oxidative stress in the dysfunction of the placental endothelial nitric oxide synthase in preeclampsia.
    Guerby P; Tasta O; Swiader A; Pont F; Bujold E; Parant O; Vayssiere C; Salvayre R; Negre-Salvayre A
    Redox Biol; 2021 Apr; 40():101861. PubMed ID: 33548859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
    Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
    J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of reversal of high glucose-induced endothelial nitric oxide synthase uncoupling by tanshinone IIA in human endothelial cell line EA.hy926.
    Zhou ZW; Xie XL; Zhou SF; Li CG
    Eur J Pharmacol; 2012 Dec; 697(1-3):97-105. PubMed ID: 23063542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydrobiopterin, but not L-arginine, decreases NO synthase uncoupling in cells expressing high levels of endothelial NO synthase.
    Bevers LM; Braam B; Post JA; van Zonneveld AJ; Rabelink TJ; Koomans HA; Verhaar MC; Joles JA
    Hypertension; 2006 Jan; 47(1):87-94. PubMed ID: 16344367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.